Small Molecules

26 Apr 2007 Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
26 Apr 2007 Basilea Reports Positive Re-treatment Results from a Second Phase III Trial of Alitretinoin for Patients with Severe Chronic Hand Eczema
26 Apr 2007 ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
26 Apr 2007 Vanda Pharmaceuticals Initiates Phase II Clinical Trial for VSF-173 in Excessive Sleepiness
26 Apr 2007 Ceragenix Commences Second in Series of Clinical Trials
26 Apr 2007 SuperGen Receives FDA Clearance to Initiate Phase I Clinical Trial With MP470
26 Apr 2007 BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
26 Apr 2007 Resverlogix Announces Milestone ApoA-l/HDL Proof-of-Concept Data
25 Apr 2007 NeuroSearch and GlaxoSmithKline initiate second clinical Phase II study with NS2359 in depression
25 Apr 2007 TopoTarget announces next Phase II clinical placebo controlled trial with Avugane(TM) in acne vulgaris
25 Apr 2007 Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
25 Apr 2007 Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
25 Apr 2007 Lexicon Advances LX1031 for Irritable Bowel Syndrome into Phase 1b Clinical Trial
25 Apr 2007 Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
25 Apr 2007 Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Nociceptive Pain in Third Molar Dental Extraction Model
25 Apr 2007 Exelixis Reinitiates Clinical Development of XL999 in Patients With Non-Small Cell Lung Cancer
25 Apr 2007 Provectus Pharmaceuticals, Inc. Completes Dosing of Patients in Phase 1 Melanoma Study
25 Apr 2007 Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
25 Apr 2007 FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients
24 Apr 2007 Oral Azacitidine Advances to Multi-Center, Multi-Cycle, Dose Escalation Study
24 Apr 2007 Application for an Additional Indication of Combination Therapy of Glufast(R) and Insulin Sensitizer in Japan
24 Apr 2007 Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment
24 Apr 2007 Pharmacyclics Announces FDA Filing of New Drug Application for Xcytrin(R) Injection to Treat Lung Cancer Brain Metastases
24 Apr 2007 Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
24 Apr 2007 AstraZeneca announces decision to discontinue collaboration with AtheroGenics regarding AGI-1067

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top